News - Zydus Cadila

Filter

Current filters:

Zydus Cadila

Popular Filters

Cadila net profit up by 82% in third-quarter

07-02-2014

Indian drugmaker Cadila Healthcare posted a net profit of 1.86 billion rupees ($29.7 million), for the…

BiosimilarsCadila PharmaceuticalsFinancialGenericsResearchZydus Cadila

Cadila pulls out of operations in Japan

Cadila pulls out of operations in Japan

28-01-2014

One of India’s largest pharmaceutical companies, Cadila Healthcare (also operating as Zydus Cadila),…

Asia-PacificFinancialIndiaPharmaceuticalZydus Cadila

Zydus Cadila settles Asacol patent litigation in USA

11-12-2013

Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

India’s Zydus Cadila posts 94% rise in 2nd-qtr net profit

31-10-2013

For the second fiscal quarter ended September 30, 2013, Indian drugmaker Zydus Cadila’s net profit…

FinancialGenericsZydus Cadila

Zydus in deal with Pieris for novel Anticalin therapeutics

16-10-2013

Indian drugmaker Zydus Cadila has entered into an alliance with privately-held German company Pieris…

Asia-PacificLicensingOncologyPharmaceuticalPieris AGPRS-110Zydus Cadila

India's Zydus and IDRI to develop new vaccine for deadly parasitic disease

25-07-2013

India's fourth largest health care group Zydus and non-profit global health organization Infectious Disease…

Asia-PacificPharmaceuticalResearchVaccinesZydus Cadila

Zydus' diabetes drug Lipaglyn becomes India's first NCE to reach the market

06-06-2013

Indian drugmaker Zydus Cadila today (June 5) made a breakthrough in its research efforts with Lipaglyn…

Asia-PacificDiabetesLipaglynPharmaceuticalRegulationZydus Cadila

Zydus Cadila's net profit up by 54% in fourth qtr

30-05-2013

Indian drugmaker Zydus Cadila posted results for the fourth quarter ended March 31, 2013, showing that…

FinancialGenericsZydus Cadila

Zydus Cadila unit launches udenafil for erectile dysfunction in India

18-07-2012

Zydus Urosciences, the specialty division of Indian drugmaker Zydus Cadila, is launching udenafil a next…

Asia-PacificDong-A PharmaceuticalsLicensingMarkets & MarketingMen's HealthPharmaceuticaludenafilUdzireZydemaZydus Cadila

Zydus Cadila third-quarter revenues up 20%

07-02-2012

Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Zydus Cadila acquires Mumbai-based Biochem

21-12-2011

Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila

Ranbaxy debuts generic Femara in UK, France and Romania; FDA OKs Zydus plant

26-07-2011

India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) which is 64% owned by Japan’s Daiichi…

Asia-PacificEuropeFemaraGenericsMarkets & MarketingNovartisOncologyRanbaxy LaboratoriesRegulationZydus Cadila

Zydus Cadila 1st-qtr fiscal net profit jumps 15%

20-07-2011

Indian drugmaker Zydus Cadila reported sales of 11.89 billion rupees ($175.2 million) for its fiscal…

FinancialGenericsZydus Cadila

K-V Pharma sells generics unit to Zydus for $60 million

20-06-2011

USA-based K-V Pharmaceutical (NYSE: KVa/KVb) has entered into a definitive agreement to divest Nesher…

GenericsK-V PharmaceuticalMergers & AcquisitionsNesher PharmaZydus Cadila

Back to top